Open Menu icon
JOIN
SEARCH
Home
Press Releases

Biosimilars Council Press Releases

Press Releases
  • Press Releases

AAM Statement on IQVIA Institute Report Examining Drug Shortages
  • Press Releases

Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022
  • Press Releases

AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law
  • Press Releases

AAM Statement on U.S. Supreme Court Decision to Decline Hearing GSK v. Teva
  • Press Releases

4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need
  • Press Releases

AAM Statement on President Biden’s Budget Plan
  • Press Releases

AAM Announces 2023 Associate Members
  • Press Releases

AAM Announces 2023 Board of Directors
  • Press Releases

New Social Media Campaign Unveiled to Raise Awareness of the Essential Role of Generic Medicine in Americans’ Lives
  • Press Releases

AAM Statement on CMMI Report
  • Press Releases

Christine Baeder Named Chair of the Association for Accessible Medicines Board of Directors
  • Press Releases

AAM Applauds CMS for Requiring Health Plans to Place Generic Drugs On Generic Tiers
Load More
JOIN
SEARCH